Neovacs

Institut National De La Sante Et De La Recherche Medicale

Institut Pasteur

Géraldine Grouard-vogel

Vincent Serra

Pierre Vandepapeliere

Olivier Dhellin

Noémie Caillot

Romain Bertrand

Bernard Fanget

Laurent Reber

Eva Conde García

Camille Roucairol

Pierre Bruhns

Pierre Vandepapelière

An immunogenic product including a cytokine conjugated with a carrier protein, wherein the cytokine is selected from the group including IL-4, IL-13 and mixtures thereof, and wherein the carrier protein is CRM. Further, a method for manufacturing the immunogenic product. Also, the therapeutic use of the immunogenic product for treating an inflammatory disorder associated with aberrant IL-4 and/or IL-13 expression or activity.

Immunogenic product comprising IL-4 and/or IL-13 for treating disorders associated with aberrant IL-4 and/or IL 13 expression or activity

An immunogenic product including IFN&#x3b1; coupled to a carrier protein molecule is capable to induce in vivo anti-IFN&#x3b1; antibodies and is useful in treating IFN&#x3b1; related conditions.

Method for treating IFNalpha related conditions

Growing community of inventors

PARIS, France

Géraldine Grouard-vogel